A
Antoinette R Tan
Researcher at Carolinas Healthcare System
Publications - 1
Citations - 350
Antoinette R Tan is an academic researcher from Carolinas Healthcare System. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 1, co-authored 1 publications receiving 245 citations.
Papers
More filters
Journal ArticleDOI
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Sung Bae Kim,Rebecca Dent,Seock-Ah Im,Marc Espié,Sibel Blau,Antoinette R Tan,Steven J Isakoff,Mafalda Oliveira,Cristina Saura,Matthew Wongchenko,Amy V. Kapp,Wai Y. Chan,Stina M. Singel,Daniel J Maslyar,José Baselga,Keun Seok Lee,Hwei Chung Wang,Antoinette R. Tan,Joohyuk Sohn,Michelino De Laurentiis,Laura G. Estévez,Chiun-Sheng Huang,Gilles Romieu,Michel Velez,Rafael Villanueva,Pierfranco Conte,Shaker R. Dakhil,Marc Debled,Antonio Gonzalez Martin,Sara A. Hurvitz,Jee Hyun Kim,Christelle Levy,Pedro Sánchez Rovira,Jae Hong Seo,Vicente Valero,Gregory Vidal,Andrea Wong,Mary Ann K Allison,Robert A. Figlin,David Chan,Shin-Cheh Chen,Yen-Hsun Chen,Melody A. Cobleigh,Filippo de Braud,Luc Dirix,Vincent Hansen,Anne Hardy Bessard,Nicholas Iannotti,Steven J. Isakoff,William E. Lawler,Alvaro Montaño,Mohamad Salkini,Leonard Seigel +52 more
TL;DR: These are the first results supporting AKT-targeted therapy for triple-negative breast cancer and Ipatasertib warrants further investigation for the treatment of triple- negative breast cancer.